Raben David bought BCAX
March 3, 2026 · Form 4 insider transaction
Raben David bought 200 shares of Bicara Therapeutics Inc. at $3.79 per share, a transaction worth $757.96. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
200
Price
$3.79
Total value
$757.96
InsiderRaben David
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after55,486
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.